Radar snapshot

28
Ingredients tracked
4
Fringe signals
5
Segments

Highest velocity signals this month

Peri-implantitis: a five-arm RCT supports standard nonsurgical care for early disease.
Hydroxyapatite (professional): CDT D2991 makes chairside regeneration billable.
Hydroxyapatite (consumer): still cosmetic-only in the US, with no anti-caries claim.
Oral probiotics: new BLIS research is mostly in vitro or animal, and not on caries or gum outcomes.

Current alerts

AmberCharcoal toothpaste, no ADA Seal or safety consensus
AmberHydroxyapatite toothpaste, no US anti-caries claim
SignalCDT D2991 chairside hydroxyapatite code
SignalPAP+ whitening adoption broadening
SignalActive US hydroxyapatite trials

This edition

1 radar position change: peri-implantitis management. 1 new entry: hydroxyapatite regeneration scaffold
0 red alerts. 1 new green signal: CDT D2991 chairside hydroxyapatite code
1 white space added: hydroxyapatite tracked as two stories, professional (billable) and consumer (claims blocked)